Print

Syapse Continues Rapid Growth, Secures Financing Led By The Social+Capital Partnership  
1/22/2013 9:27:25 AM

PALO ALTO, Calif.--(BUSINESS WIRE)--Syapse, the leader in bringing omics into routine medical use, announced unprecedented momentum in helping laboratories and clinics generate and use next-generation sequencing to diagnose and treat patients. Syapse software is now involved in the processing of over 3,000 patient genomes and thousands of transcriptome, proteome, immunome, and microbiome profiles per quarter. With 100 billion omics and clinical data points and 10 terabytes of data under management, Syapse is one of the largest repositories of human molecular profiles.